A Gene Locus Responsible for Dyschromatosis Symmetrica Hereditaria (DSH) Maps to Chromosome 6q24.2-q25.2  by Xing, Qing-he et al.
Am. J. Hum. Genet. 73:377–382, 2003
377
Report
A Gene Locus Responsible for Dyschromatosis Symmetrica Hereditaria
(DSH) Maps to Chromosome 6q24.2-q25.2
Qing-he Xing,1,2,* Ming-tai Wang,7* Xiang-dong Chen,3 Guo-yin Feng,4 Hong-yun Ji,5
Jian-dong Yang,1,2 Jian-jun Gao,1,2 Wei Qin,1,2 Xue-qing Qian,1,2 Sheng-nan Wu,1,2
and Lin He2,6
1Institute of Nutrition Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 2Bio-X Life Science Research Center,
Shanghai Jiao Tong University, 3Shanghai Ninth People’s Hospital, Shanghai Second Medical University,4 Shanghai Mental Health Center,
5Department of Ophthalmology, Shanghai Hospital of Integrated Traditional and Western Medicine, and 6Institute of Nutrition Science,
Chinese Academy of Sciences, Shanghai; and 7The Second Affiliated Hospital, Zhengzhou University, Zhengzhou, China
Dyschromatosis symmetrica hereditaria (DSH) is a hereditary skin disease characterized by the presence of hyper-
pigmented and hypopigmented macules on extremities and face. The gene, or even its chromosomal location, for
DSH has not yet been identified. In this study, two Chinese families with DSH were identified and subjected to a
genomewide screen for linkage analysis. Two-point linkage analysis for pedigree A (maximum LOD score [Zmax]p
7.28 at recombination fraction [v] p 0.00) and pedigree B (Zmax p 2.41 at v p 0.00) mapped the locus for DSH
in the two families to chromosome 6q. Subsequent multipoint analysis of the two families also provided additional
support for the DSH gene being located within the region 6q24.2-q25.2, with Zmax p 10.64. Haplotype analysis
confined the locus within an interval of 10.2 Mbp, flanked by markers D6S1703 and D6S1708. The two families
had no identical haplotype within the defined region, which suggests that the two families were different in origin.
Further work on identification of the gene for DSH will open new avenues to exploration of the genetics of
pigmentation.
Dyschromatosis symmetrica hereditaria (DSH [MIM
127400]), also called “symmetric dyschromatosis of the
extremities” or “reticulate acropigmentation of Dohi,”
was first reported by Matsumoto (1923) and named by
Toyama as a clinical entity (Toyama 1929). DSH gen-
erally shows an autosomal dominant pattern of inheri-
tance, with high penetrance (Oyama et al. 1999). DSH
can be characterized by hyperpigmented and hypopig-
mented macules, on face and dorsal aspects of extremi-
ties, that appear in infancy or early childhood (Patrizi et
al. 1994; Ostlere et al. 1995; Danese et al. 1997; Oyama
et al. 1999; Ohtoshi et al. 2001). The skin lesions com-
monly stop spreading before adolescence but last for life.
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These abnormalities are otherwise asymptomatic and do
not affect general health. Histologically, melanin pigmen-
tation was increased in the basal cells of hyperpigmented
lesions, but the numbers of melanocytes were decreased
in hypopigmented macules (Oyama et al. 1999). Electron
microscopic findings in a hypermelanotic area showed an
increased number of melanocytes with high metabolic ac-
tivity. In the hypomelanotic areas, the melanocytes were
morphologically abnormal, with melanosomes at the
early stages of development (Danese et al. 1997; Ohtoshi
et al. 2001).
In Asia, DSH occurs predominantly among Japanese
and Korean individuals (Danese et al. 1997; Oyama et
al. 1999) but has been reported in other Asian countries
to a lesser extent (Tan and Tay 1997; Hemanthkumar
and Thappa 1997). Because DSH is a relatively common
phenotype in the white population, particularly in red-
heads, in the West, there is great concern about DSH.
So far, many clinical and morphological investigations
have been reported, but the DSH gene—including the
pathogenesis—has not yet been identified (Kono et al.
2000). In an effort to localize the gene for DSH, we
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embarked on a genomewide search and found significant
evidence for linkage of the gene responsible for DSH to
chromosome 6q24.2-25.2.
Two families from the Henan and Yunnan provinces
of China with typical features of DSH were recruited for
this work. Both pedigrees with DSH showed an auto-
somal dominant inheritance pattern (fig. 1) and were
ascertained by the Huashan Hospital of Fudan Univer-
sity, the First Affiliated Hospital of Zhengzhou Univer-
sity, and the Shanghai Ninth People’s Hospital of Shang-
hai Second Medical University. The affected individuals
had symmetrical cutaneous hypopigmented and hyper-
pigmented macules, ranging in size from pea-sized to
covering the backs of fingers and the backs of hands.
The similar distributions could be found on feet and even
on trunks (fig. 2). Biopsies of hyperpigmented and hy-
popigmented macules on the tops of the feet revealed
basal melanosis and hypomelanosis, which were similar
to the reports on Japanese subjects. Nevertheless, none
of the affected members in either family was found to
have skin cancer.
This research has been approved by the ethical review
committees of the appropriate institutions. In total, 50
family members participated in this study, after having
given informed consent. Samples of peripheral-blood
DNA were taken from all available family members, and
DNA was prepared by means of our standard procedure
(Gao et al. 2001; Liu et al. 2001). In linkage analysis,
the samples were analyzed individually, rather than by the
DNA-pooling method usually used in our other work (Liu
et al. 2001).
We therefore performed a genomewide scan in these
two Chinese families with DSH to determine the chro-
mosomal regions linked to DSH, using 382 polymorphic
microsatellite markers covering 22 autosomes, with an
average marker density of 10 cM, according to the Ge´-
ne´thon linkage map. The markers used were from the ABI
Prism Linkage Mapping Set (version 2.0) and the Ge´ne´-
thon Human Linkage Map (Dib et al. 1996). Marker
order and intermarker distances were obtained from
linkage map of the Cooperative Human Linkage Center
(CHLC). Semiautomated fluorescence genotyping was
adopted to type the microsatellite markers (Yang et al.
2000). PCR was performed under the conditions rec-
ommended by the manufacturer (PE Biosystems). PCR
products were mixed with a loading cocktail that con-
tained formamide, Gs-400HD ROX standards (PE Bio-
systems), and loading dye. The product was loaded onto
6% acrylamide gel and run in an ABI 377 Prism DNA
Sequencer (Perkin Elmer). The data were analyzed by
ABI GENESCAN 3.1 and ABI GENOTYPER 2.1 soft-
ware (PE Biosystems).
A two-point LOD score was calculated, by use of the
MLINK routine of the FASTLINK software package ver-
sion 5.1 (Lathrop and Lalouel 1984), under an assumed
genetic model: autosomal dominant, a disease-allele fre-
quency of 0.0001, evenly shared allele frequency, zero
phenocopy rate, no sex difference, and full penetrance
(Kono et al. 2000). Multipoint analysis was performed
with the FASTMAP program (Curtis and Gurling 1993).
Initial evidence of linkage to DSH was obtained in
pedigree A at marker D6S1581, from which a LOD score
of 2.24 was obtained at . In further refinementvp 0.05
study with high-density markers in the same region, we
confirmed the finding with the highest LOD score (Zmax)
of 7.28 (recombination fraction [v] p 0.00) at marker
D6S1654 (table 1). Conversely, no significant linkage
with markers on other chromosomal regions was found.
Subsequent multipoint analysis carried out with FAST-
MAP also provided additional support for the locali-
zation of DSH locus to chromosome 6q24.2-q25.2, with
. In the next study of pedigree B, using theZ p 7.84max
markers that generated positive results for pedigree A, we
obtained at at marker D6S448,Z p 2.41 vp 0.00max
which is positioned ∼2.9 cM away from D6S1654 (table
1). The multipoint analysis produced in theZ p 3.09max
same region. Obviously, the results suggest that the gene
locus responsible for the disorder in family B is also
localized in chromosome 6q, in light of the restricted size
of the family. The combined multipoint LOD score for
both families is 10.64 around marker D6S1553.
Subsequent haplotypes were performed with Cyrillic
version 2.1 (Cherwell Scientific) to confine interval of the
linked region (fig. 1). The recombination events between
the DSH phenotype and the markers that span the region
of interest defined the smallest cosegregating region that
included critical meiotic recombinants in pedigree A.
Careful examination of the haplotypes confirmed that
disease-associated alleles cosegregated with the phenotype
of DSH in pedigree A. A recombination event in individ-
ual III-8 placed the disease locus proximal to D6S1703,
since the affected individual did not inherit the disease-
linked alleles of D6S1703 in family A. A recombination
event in individual IV-14 placed the disease locus distal
to D6S1708, since this affected individual did not share
the disease-linked alleles of D6S1708 in family A. Hence,
the maximal interval of linkage with DSH phenotype is
bordered by D6S1703 (centromeric) and D6S1708 (telo-
meric) within a region of ∼10.2 Mbp, according to the
last draft of the human genome sequence (Build 31).
The haplotype construction of pedigree B showed that
the affected individuals shared a common allele, for the
markers in the susceptibility region, that was not shared
by the healthy individuals. This suggests that the gene
responsible for the disorder in family B is also localized
in chromosome 6q24.2-q25.2. However, the haplotypes
in the two families contain the same contiguous markers
but with different alleles. In this study, we seem to en-
counter the similar situation: that the two families may
share the same disorder-causing gene but of different ori-
Figure 1 Pedigree structure and haplotypes of family A (A) and family B (B). Marker order was determined from the Ge´ne´thon sex-
averaged genetic map, the CHLC sex-averaged genetic map, and the Genome Database. Open symbols indicate unaffected individuals, blackened
symbols indicate affected individuals, squares indicate men, and circles indicate women. Blackened bars indicate the chromosome region shared
by affected members of the pedigree.
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Figure 2 A mixture of hypopigmented and hyperpigmented macules of various sizes on the trunk and arms of DSH-affected individuals
in pedigree A (A) and pedigree B (B), respectively.
gin (Yang et al. 2000). However, the above results well
demonstrate that at least one gene responsible for DSH,
likely with different mutations, is located within the same
region (Gao et al. 2001).
Clinical manifestations of DSH are dominated by hy-
perpigmented and hypopigmented macules of various
sizes on the face and extremities, even on the trunk. Mela-
nin pigmentation plays an important role in protecting
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Table 1
Two-Point LOD Scores Obtained from Linkage Analysis between
DSH Locus and Chromosome 6q Markers in Two Pedigrees
LOD Score at v p
Locus and Pedigree .0 .01 .05 .1 .2 .3 .4
D6S1569:
Ped A  2.22 .45 .03 .13 .04 .03
Ped B 1.51 1.47 1.35 1.19 .83 .46 .13
D6S1703:
Ped A  3.74 4.06 3.87 3.12 2.13 1.02
Ped B 1.20 1.19 1.12 1.02 .82 .58 .32
D6S311:
Ped A 3.59 3.53 3.29 2.98 2.31 1.59 .83
Ped B 2.11 2.07 1.93 1.74 1.33 .87 .39
D6S1564:
Ped A 4.63 4.55 4.24 3.83 2.94 1.97 .91
Ped B .87 .85 .78 .70 .52 .35 .17
D6S1553:
Ped A 6.98 6.87 6.41 5.81 4.52 3.08 1.49
Ped B 2.11 2.07 1.93 1.74 1.33 .87 .39
D6S1654:
Ped A 7.28 7.16 6.69 6.06 4.72 3.22 1.57
Ped B 2.11 2.07 1.93 1.74 1.33 .87 .39
D6S448:
Ped A 6.39 6.28 5.82 5.23 3.94 2.55 1.12
Ped B 2.41 2.37 2.21 2.00 1.54 1.02 .47
D6S1556:
Ped A 3.29 3.23 3.01 2.72 2.11 1.45 .75
Ped B 2.07 2.03 1.87 1.67 1.24 .78 .32
D6S1708:
Ped A  3.24 3.56 3.38 2.70 1.87 .92
Ped B 1.20 1.18 1.09 .98 .72 .44 .15
D6S1581:
Ped A  1.15 2.24 2.43 2.14 1.52 .72
Ped B 1.20 1.19 1.12 1.02 .82 .58 .32
skin against the damaging effects of ultraviolet rays. Al-
though DSH is a disorder of pigmentation, no evidence
has been found that DSH confers an increased risk of
forming melanoma. In several cases, skin lesions were
reported to become more pronounced after sun exposure,
but there was no evidence revealed of photosensitivity
(Satoh and Yoshida 1980).
Several human genetic diseases, such as LEOPARD syn-
drome (MIM 151100) and xeroderma pigmentation (XP),
show some overlap with DSH. LEOPARD syndrome is
an autosomal dominant inheritance characterized by mul-
tiple lentigines, electrocardiographic conduction abnor-
malities, ocular hypertelorism, pulmonic stenosis, abnor-
mal genitalia, retardation of growth, and sensorineural
deafness (Voron et al. 1976). Diffuse lentiginosis is a dis-
tinct characteristic of LEOPARD syndrome and similar
to hyperpigmented macules of DSH. However, DSH has
hypopigmentation macules and no common associated
disorders. In addition, the gene for LEOPARD syndrome
has previously been mapped to chromosome 12q24.1.
Thus, the genetic basis of DSH is likely to differ from that
of LEOPARD syndrome. With regard to XP, it is an au-
tosomal recessive syndrome with clinical manifestations
of excessive freckling, depigmentation, hyperpigmenta-
tion, skin aging, and a very high level of early and multiple
skin cancers (Stary and Sarasin 2002). Although a mild
type of XP also resembles DSH, DSH does not show the
xerosis, atrophy, telangiectasia, or skin tumors usually
observed in XP.
DSH is also likely to be genetically heterogeneous, since
examples of an autosomal dominant (Oyama et al. 1999)
and autosomal recessive (Urabe and Hori 1997; Alfadley
et al. 2000) inheritance have been reported. In this work,
we have mapped dominant DSH to the region within 10.2
Mbp of chromosome 6q24.2-q25.2, where there have
been 160 possible genes identified. It is unfortunate that
no gene or sequence in the region has been found to be
homologous to any of 1100 known loci that affect pig-
mentation in the mouse, according to the search of all
currently available databases (Coat Color Genes) (Jack-
son 1997; Nakamura et al. 2002). However, several genes
in this region—such as RGS17 (MIM 607191), AKAP12
(MIM 604698), and MAP3K7IP2 (MIM 605101), which
play roles in signal pathways—can be considered as can-
didate genes for DSH. The products of RGS17, a member
of the regulators of G protein–signaling (RGS) proteins
that contain homologous core domains (RGS domains)
of∼120 amino acids, are important regulatory and struc-
tural components of G protein–coupled receptor com-
plexes and are involved in modulating a variety of cell
functions, such as proliferation, differentiation, response
to neurotransmitters, membrane trafficking, and embry-
onic development (De Vries and Gist Farquhar 1999;
Sierra et al. 2002). We are currently making efforts in
identification of these candidate genes.
In conclusion, on the basis of this work, we clearly
show that a major gene responsible for dominant DSH
in the human genome has been first localized in the re-
gion of chromosome 6q24.2-q25.2. The characteriza-
tion of the DSH gene will provide important clues to
understand the molecular mechanism of pigmentation
and increase ultimate hope for effectively interventional
strategies.
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